May
22
Sun
Prostate Cancer CME Series: Treatment Across the Prostate Cancer Continuum for Primary Care Clinicians (RECORDING) @ Online
May 22 all-day

Internet Enduring Material sponsored and presented by the Center for Continuing Medical Education at the Stanford School of Medicine. This is a recorded presentation of the Prostate Cancer CME Series: Treatment Across the Prostate Cancer Continuum for Primary Care Clinicians held on Monday, March 21, 2022 The goal of the series is to enhance understanding of increasingly complex treatment options and close knowledge gaps in earlier stages of prostate cancer. This session was targeted towards the primary care clinicians and included a discussion on the historical landscape of testing, blood based diagnostic biomarkers and screening, the latest in diagnostics, role of genetics and genomics and highlight existing disparities in prostate cancer.

Registration

Release Date: April 8, 2022
Expiration Date: April 7, 2023
Estimated Time to Complete: 2.0 hours
Registration Fee: FREE
*Originally recorded on March 27, 2022 

Credits

AMA PRA Category 1 Credits™ (2.00 hours), Non-Physician Participation Credit (2.00 hours), ANCC Contact Hours (2.00 hours), ACPE Contact Hours (2.00 hours)

Target Audience

Specialties – Family Medicine & Community Health, Hospital Medicine, Focused Practice, Internal Medicine, Medical Oncology

Professions – Advance Practice Nurse (APN), Nurse, Pharmacist (Pharm D)(BSPharm), Physician, Professional Nurse (RN)

Objectives

At the conclusion of this activity, learners should be able to:

  • Identify the different prostate cancer disease states in the castration-sensitive prostate cancer (CSPC) setting.
  • Navigate the lack of consensus in how to care for patients with prostate cancer in early stages of disease.
  • Explain the historical landscape of testing and screening in prostate cancer.
  • Describe the implications of health disparities in prostate cancer screening and treatment.

Accreditation

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation
American Medical Association (AMA) 

Stanford Medicine designates this Enduring Material for a maximum of 2.00 AMA PRA Category 1 CreditsTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accreditation Council of Pharmacy Education (ACPE) 
Stanford Medicine designates this knowledge-based activity for a maximum of 2 hours. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion. UAN: JA0000751-0000-22-005-H01-P

American Nurses Credentialing Center (ANCC) 
Stanford Medicine designates this internet enduring activity for a maximum of 2.0 ANCC contact hours.

For Pharmacists to Claim ACPE Credit
If you wish to apply for ACPE credit, please enter your NABP ePID# and Date of Birth in your CE Profile.
Go to Stanford’s CME portal > My CE > Profile tile > Credentials > Select NABP ePID# from the drop down and enter your ID number.
Please also enter your Date of Birth (month and day) in your profile under Basic Information.  The field will appear when you select your Profession as Pharmacist.

May
23
Mon
Prostate Cancer CME Series: Treatment Across the Prostate Cancer Continuum for Primary Care Clinicians (RECORDING) @ Online
May 23 all-day

Internet Enduring Material sponsored and presented by the Center for Continuing Medical Education at the Stanford School of Medicine. This is a recorded presentation of the Prostate Cancer CME Series: Treatment Across the Prostate Cancer Continuum for Primary Care Clinicians held on Monday, March 21, 2022 The goal of the series is to enhance understanding of increasingly complex treatment options and close knowledge gaps in earlier stages of prostate cancer. This session was targeted towards the primary care clinicians and included a discussion on the historical landscape of testing, blood based diagnostic biomarkers and screening, the latest in diagnostics, role of genetics and genomics and highlight existing disparities in prostate cancer.

Registration

Release Date: April 8, 2022
Expiration Date: April 7, 2023
Estimated Time to Complete: 2.0 hours
Registration Fee: FREE
*Originally recorded on March 27, 2022 

Credits

AMA PRA Category 1 Credits™ (2.00 hours), Non-Physician Participation Credit (2.00 hours), ANCC Contact Hours (2.00 hours), ACPE Contact Hours (2.00 hours)

Target Audience

Specialties – Family Medicine & Community Health, Hospital Medicine, Focused Practice, Internal Medicine, Medical Oncology

Professions – Advance Practice Nurse (APN), Nurse, Pharmacist (Pharm D)(BSPharm), Physician, Professional Nurse (RN)

Objectives

At the conclusion of this activity, learners should be able to:

  • Identify the different prostate cancer disease states in the castration-sensitive prostate cancer (CSPC) setting.
  • Navigate the lack of consensus in how to care for patients with prostate cancer in early stages of disease.
  • Explain the historical landscape of testing and screening in prostate cancer.
  • Describe the implications of health disparities in prostate cancer screening and treatment.

Accreditation

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation
American Medical Association (AMA) 

Stanford Medicine designates this Enduring Material for a maximum of 2.00 AMA PRA Category 1 CreditsTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accreditation Council of Pharmacy Education (ACPE) 
Stanford Medicine designates this knowledge-based activity for a maximum of 2 hours. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion. UAN: JA0000751-0000-22-005-H01-P

American Nurses Credentialing Center (ANCC) 
Stanford Medicine designates this internet enduring activity for a maximum of 2.0 ANCC contact hours.

For Pharmacists to Claim ACPE Credit
If you wish to apply for ACPE credit, please enter your NABP ePID# and Date of Birth in your CE Profile.
Go to Stanford’s CME portal > My CE > Profile tile > Credentials > Select NABP ePID# from the drop down and enter your ID number.
Please also enter your Date of Birth (month and day) in your profile under Basic Information.  The field will appear when you select your Profession as Pharmacist.

May
24
Tue
Prostate Cancer CME Series: Treatment Across the Prostate Cancer Continuum for Primary Care Clinicians (RECORDING) @ Online
May 24 all-day

Internet Enduring Material sponsored and presented by the Center for Continuing Medical Education at the Stanford School of Medicine. This is a recorded presentation of the Prostate Cancer CME Series: Treatment Across the Prostate Cancer Continuum for Primary Care Clinicians held on Monday, March 21, 2022 The goal of the series is to enhance understanding of increasingly complex treatment options and close knowledge gaps in earlier stages of prostate cancer. This session was targeted towards the primary care clinicians and included a discussion on the historical landscape of testing, blood based diagnostic biomarkers and screening, the latest in diagnostics, role of genetics and genomics and highlight existing disparities in prostate cancer.

Registration

Release Date: April 8, 2022
Expiration Date: April 7, 2023
Estimated Time to Complete: 2.0 hours
Registration Fee: FREE
*Originally recorded on March 27, 2022 

Credits

AMA PRA Category 1 Credits™ (2.00 hours), Non-Physician Participation Credit (2.00 hours), ANCC Contact Hours (2.00 hours), ACPE Contact Hours (2.00 hours)

Target Audience

Specialties – Family Medicine & Community Health, Hospital Medicine, Focused Practice, Internal Medicine, Medical Oncology

Professions – Advance Practice Nurse (APN), Nurse, Pharmacist (Pharm D)(BSPharm), Physician, Professional Nurse (RN)

Objectives

At the conclusion of this activity, learners should be able to:

  • Identify the different prostate cancer disease states in the castration-sensitive prostate cancer (CSPC) setting.
  • Navigate the lack of consensus in how to care for patients with prostate cancer in early stages of disease.
  • Explain the historical landscape of testing and screening in prostate cancer.
  • Describe the implications of health disparities in prostate cancer screening and treatment.

Accreditation

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation
American Medical Association (AMA) 

Stanford Medicine designates this Enduring Material for a maximum of 2.00 AMA PRA Category 1 CreditsTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accreditation Council of Pharmacy Education (ACPE) 
Stanford Medicine designates this knowledge-based activity for a maximum of 2 hours. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion. UAN: JA0000751-0000-22-005-H01-P

American Nurses Credentialing Center (ANCC) 
Stanford Medicine designates this internet enduring activity for a maximum of 2.0 ANCC contact hours.

For Pharmacists to Claim ACPE Credit
If you wish to apply for ACPE credit, please enter your NABP ePID# and Date of Birth in your CE Profile.
Go to Stanford’s CME portal > My CE > Profile tile > Credentials > Select NABP ePID# from the drop down and enter your ID number.
Please also enter your Date of Birth (month and day) in your profile under Basic Information.  The field will appear when you select your Profession as Pharmacist.

Frontiers in Cancer Clinical Translation Seminar Series: “Using machine learning to optimize quality of care delivery for patients with cancer” @ Stanford Zoom
May 24 @ 8:00 am – 9:00 am
Frontiers in Cancer Clinical Translation Seminar Series: "Using machine learning to optimize quality of care delivery for patients with cancer" @ Stanford Zoom

Title: “Using machine learning to optimize quality of care delivery for patients with cancer”

Speaker: Michael Francis Gensheimer

Clinical Associate Professor, Department of Radiation Oncology

May
25
Wed
Prostate Cancer CME Series: Treatment Across the Prostate Cancer Continuum for Primary Care Clinicians (RECORDING) @ Online
May 25 all-day

Internet Enduring Material sponsored and presented by the Center for Continuing Medical Education at the Stanford School of Medicine. This is a recorded presentation of the Prostate Cancer CME Series: Treatment Across the Prostate Cancer Continuum for Primary Care Clinicians held on Monday, March 21, 2022 The goal of the series is to enhance understanding of increasingly complex treatment options and close knowledge gaps in earlier stages of prostate cancer. This session was targeted towards the primary care clinicians and included a discussion on the historical landscape of testing, blood based diagnostic biomarkers and screening, the latest in diagnostics, role of genetics and genomics and highlight existing disparities in prostate cancer.

Registration

Release Date: April 8, 2022
Expiration Date: April 7, 2023
Estimated Time to Complete: 2.0 hours
Registration Fee: FREE
*Originally recorded on March 27, 2022 

Credits

AMA PRA Category 1 Credits™ (2.00 hours), Non-Physician Participation Credit (2.00 hours), ANCC Contact Hours (2.00 hours), ACPE Contact Hours (2.00 hours)

Target Audience

Specialties – Family Medicine & Community Health, Hospital Medicine, Focused Practice, Internal Medicine, Medical Oncology

Professions – Advance Practice Nurse (APN), Nurse, Pharmacist (Pharm D)(BSPharm), Physician, Professional Nurse (RN)

Objectives

At the conclusion of this activity, learners should be able to:

  • Identify the different prostate cancer disease states in the castration-sensitive prostate cancer (CSPC) setting.
  • Navigate the lack of consensus in how to care for patients with prostate cancer in early stages of disease.
  • Explain the historical landscape of testing and screening in prostate cancer.
  • Describe the implications of health disparities in prostate cancer screening and treatment.

Accreditation

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation
American Medical Association (AMA) 

Stanford Medicine designates this Enduring Material for a maximum of 2.00 AMA PRA Category 1 CreditsTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accreditation Council of Pharmacy Education (ACPE) 
Stanford Medicine designates this knowledge-based activity for a maximum of 2 hours. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion. UAN: JA0000751-0000-22-005-H01-P

American Nurses Credentialing Center (ANCC) 
Stanford Medicine designates this internet enduring activity for a maximum of 2.0 ANCC contact hours.

For Pharmacists to Claim ACPE Credit
If you wish to apply for ACPE credit, please enter your NABP ePID# and Date of Birth in your CE Profile.
Go to Stanford’s CME portal > My CE > Profile tile > Credentials > Select NABP ePID# from the drop down and enter your ID number.
Please also enter your Date of Birth (month and day) in your profile under Basic Information.  The field will appear when you select your Profession as Pharmacist.

SCCR Virtual Science Series: Beyond the Basics – A Primer on Oncology @ Zoom Meeting Link
May 25 @ 9:00 am – 11:00 am
SCCR Virtual Science Series: Beyond the Basics - A Primer on Oncology @ Zoom Meeting Link

Presenter: Dr. Manali I. Patel, MD

Click HERE to Register!

Zoom Class Link

The mission of the Stanford Center for Clinical Research (SCCR) includes offering educational resources, training, and support for investigators and research staff.  We have invited the Assistant Professor of Medicine in Oncology, Dr. Manali I. Patel, MD, to provide you with the principles of oncology and treatments. The speaker will review etiologies and determinants for disparities. She will also review research areas including delivery science and its application to care delivery for patients with oncologic diseases.

At the conclusion of this class, you will be able to:

  • Apply principles of Cancer Epidemiology
  • Examine Screening Policies and Implications for Cancer
  • Explain principles of ZNA as etiologies for disparities in cancer development and outcomes
  • Analyze barriers that lead to disparities across the cancer continuum
  • Apply strategies to overcome barriers in current cancer care delivery

Attendance is open to all research staff.

About the Instructors:

Dr. Manali I. Patel, MD, is a medical thoracic oncologist and health services researcher at the Stanford University School of Medicine and the Veterans Affairs Palo Alto Health Care System. She obtained her MD and Masters in Public Health at UNC-Chapel Hill and completed her Internal Medicine residency, fellowship in Hematology and Oncology, and Masters in Science in Health Services Research at Stanford University.  Dr. Patel’s research involves evaluating systems-level and social factors that influence disparities in cancer and value-based care delivery. Her expertise lies in designing, implementing, and evaluating new models of cancer care delivery with academic, community, and VA oncology practices aimed to improve patient experiences with care, clinical outcomes, and reduce unwanted healthcare utilization and health disparities. Dr. Patel also has expertise in linking large cancer registries to investigate modifiable etiologies for disparate care receipt among populations.

BRN OPTIONAL 

Spectrum is an approved provider by the California Board of Registered Nursing, Provider Number CEP15435 for 2 contact hour(s).
To receive your certificate with BRN credit, you are required to complete an evaluation at the conclusion of this class.
BRN Cancellation Policy: If you wish to cancel your registration, please contact the course coordinators, Susan Saba, ssaba@stanford.edu.

May
26
Thu
Prostate Cancer CME Series: Treatment Across the Prostate Cancer Continuum for Primary Care Clinicians (RECORDING) @ Online
May 26 all-day

Internet Enduring Material sponsored and presented by the Center for Continuing Medical Education at the Stanford School of Medicine. This is a recorded presentation of the Prostate Cancer CME Series: Treatment Across the Prostate Cancer Continuum for Primary Care Clinicians held on Monday, March 21, 2022 The goal of the series is to enhance understanding of increasingly complex treatment options and close knowledge gaps in earlier stages of prostate cancer. This session was targeted towards the primary care clinicians and included a discussion on the historical landscape of testing, blood based diagnostic biomarkers and screening, the latest in diagnostics, role of genetics and genomics and highlight existing disparities in prostate cancer.

Registration

Release Date: April 8, 2022
Expiration Date: April 7, 2023
Estimated Time to Complete: 2.0 hours
Registration Fee: FREE
*Originally recorded on March 27, 2022 

Credits

AMA PRA Category 1 Credits™ (2.00 hours), Non-Physician Participation Credit (2.00 hours), ANCC Contact Hours (2.00 hours), ACPE Contact Hours (2.00 hours)

Target Audience

Specialties – Family Medicine & Community Health, Hospital Medicine, Focused Practice, Internal Medicine, Medical Oncology

Professions – Advance Practice Nurse (APN), Nurse, Pharmacist (Pharm D)(BSPharm), Physician, Professional Nurse (RN)

Objectives

At the conclusion of this activity, learners should be able to:

  • Identify the different prostate cancer disease states in the castration-sensitive prostate cancer (CSPC) setting.
  • Navigate the lack of consensus in how to care for patients with prostate cancer in early stages of disease.
  • Explain the historical landscape of testing and screening in prostate cancer.
  • Describe the implications of health disparities in prostate cancer screening and treatment.

Accreditation

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation
American Medical Association (AMA) 

Stanford Medicine designates this Enduring Material for a maximum of 2.00 AMA PRA Category 1 CreditsTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accreditation Council of Pharmacy Education (ACPE) 
Stanford Medicine designates this knowledge-based activity for a maximum of 2 hours. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion. UAN: JA0000751-0000-22-005-H01-P

American Nurses Credentialing Center (ANCC) 
Stanford Medicine designates this internet enduring activity for a maximum of 2.0 ANCC contact hours.

For Pharmacists to Claim ACPE Credit
If you wish to apply for ACPE credit, please enter your NABP ePID# and Date of Birth in your CE Profile.
Go to Stanford’s CME portal > My CE > Profile tile > Credentials > Select NABP ePID# from the drop down and enter your ID number.
Please also enter your Date of Birth (month and day) in your profile under Basic Information.  The field will appear when you select your Profession as Pharmacist.

May
27
Fri
Prostate Cancer CME Series: Treatment Across the Prostate Cancer Continuum for Primary Care Clinicians (RECORDING) @ Online
May 27 all-day

Internet Enduring Material sponsored and presented by the Center for Continuing Medical Education at the Stanford School of Medicine. This is a recorded presentation of the Prostate Cancer CME Series: Treatment Across the Prostate Cancer Continuum for Primary Care Clinicians held on Monday, March 21, 2022 The goal of the series is to enhance understanding of increasingly complex treatment options and close knowledge gaps in earlier stages of prostate cancer. This session was targeted towards the primary care clinicians and included a discussion on the historical landscape of testing, blood based diagnostic biomarkers and screening, the latest in diagnostics, role of genetics and genomics and highlight existing disparities in prostate cancer.

Registration

Release Date: April 8, 2022
Expiration Date: April 7, 2023
Estimated Time to Complete: 2.0 hours
Registration Fee: FREE
*Originally recorded on March 27, 2022 

Credits

AMA PRA Category 1 Credits™ (2.00 hours), Non-Physician Participation Credit (2.00 hours), ANCC Contact Hours (2.00 hours), ACPE Contact Hours (2.00 hours)

Target Audience

Specialties – Family Medicine & Community Health, Hospital Medicine, Focused Practice, Internal Medicine, Medical Oncology

Professions – Advance Practice Nurse (APN), Nurse, Pharmacist (Pharm D)(BSPharm), Physician, Professional Nurse (RN)

Objectives

At the conclusion of this activity, learners should be able to:

  • Identify the different prostate cancer disease states in the castration-sensitive prostate cancer (CSPC) setting.
  • Navigate the lack of consensus in how to care for patients with prostate cancer in early stages of disease.
  • Explain the historical landscape of testing and screening in prostate cancer.
  • Describe the implications of health disparities in prostate cancer screening and treatment.

Accreditation

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation
American Medical Association (AMA) 

Stanford Medicine designates this Enduring Material for a maximum of 2.00 AMA PRA Category 1 CreditsTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accreditation Council of Pharmacy Education (ACPE) 
Stanford Medicine designates this knowledge-based activity for a maximum of 2 hours. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion. UAN: JA0000751-0000-22-005-H01-P

American Nurses Credentialing Center (ANCC) 
Stanford Medicine designates this internet enduring activity for a maximum of 2.0 ANCC contact hours.

For Pharmacists to Claim ACPE Credit
If you wish to apply for ACPE credit, please enter your NABP ePID# and Date of Birth in your CE Profile.
Go to Stanford’s CME portal > My CE > Profile tile > Credentials > Select NABP ePID# from the drop down and enter your ID number.
Please also enter your Date of Birth (month and day) in your profile under Basic Information.  The field will appear when you select your Profession as Pharmacist.

May
28
Sat
Prostate Cancer CME Series: Treatment Across the Prostate Cancer Continuum for Primary Care Clinicians (RECORDING) @ Online
May 28 all-day

Internet Enduring Material sponsored and presented by the Center for Continuing Medical Education at the Stanford School of Medicine. This is a recorded presentation of the Prostate Cancer CME Series: Treatment Across the Prostate Cancer Continuum for Primary Care Clinicians held on Monday, March 21, 2022 The goal of the series is to enhance understanding of increasingly complex treatment options and close knowledge gaps in earlier stages of prostate cancer. This session was targeted towards the primary care clinicians and included a discussion on the historical landscape of testing, blood based diagnostic biomarkers and screening, the latest in diagnostics, role of genetics and genomics and highlight existing disparities in prostate cancer.

Registration

Release Date: April 8, 2022
Expiration Date: April 7, 2023
Estimated Time to Complete: 2.0 hours
Registration Fee: FREE
*Originally recorded on March 27, 2022 

Credits

AMA PRA Category 1 Credits™ (2.00 hours), Non-Physician Participation Credit (2.00 hours), ANCC Contact Hours (2.00 hours), ACPE Contact Hours (2.00 hours)

Target Audience

Specialties – Family Medicine & Community Health, Hospital Medicine, Focused Practice, Internal Medicine, Medical Oncology

Professions – Advance Practice Nurse (APN), Nurse, Pharmacist (Pharm D)(BSPharm), Physician, Professional Nurse (RN)

Objectives

At the conclusion of this activity, learners should be able to:

  • Identify the different prostate cancer disease states in the castration-sensitive prostate cancer (CSPC) setting.
  • Navigate the lack of consensus in how to care for patients with prostate cancer in early stages of disease.
  • Explain the historical landscape of testing and screening in prostate cancer.
  • Describe the implications of health disparities in prostate cancer screening and treatment.

Accreditation

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation
American Medical Association (AMA) 

Stanford Medicine designates this Enduring Material for a maximum of 2.00 AMA PRA Category 1 CreditsTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accreditation Council of Pharmacy Education (ACPE) 
Stanford Medicine designates this knowledge-based activity for a maximum of 2 hours. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion. UAN: JA0000751-0000-22-005-H01-P

American Nurses Credentialing Center (ANCC) 
Stanford Medicine designates this internet enduring activity for a maximum of 2.0 ANCC contact hours.

For Pharmacists to Claim ACPE Credit
If you wish to apply for ACPE credit, please enter your NABP ePID# and Date of Birth in your CE Profile.
Go to Stanford’s CME portal > My CE > Profile tile > Credentials > Select NABP ePID# from the drop down and enter your ID number.
Please also enter your Date of Birth (month and day) in your profile under Basic Information.  The field will appear when you select your Profession as Pharmacist.

May
29
Sun
Prostate Cancer CME Series: Treatment Across the Prostate Cancer Continuum for Primary Care Clinicians (RECORDING) @ Online
May 29 all-day

Internet Enduring Material sponsored and presented by the Center for Continuing Medical Education at the Stanford School of Medicine. This is a recorded presentation of the Prostate Cancer CME Series: Treatment Across the Prostate Cancer Continuum for Primary Care Clinicians held on Monday, March 21, 2022 The goal of the series is to enhance understanding of increasingly complex treatment options and close knowledge gaps in earlier stages of prostate cancer. This session was targeted towards the primary care clinicians and included a discussion on the historical landscape of testing, blood based diagnostic biomarkers and screening, the latest in diagnostics, role of genetics and genomics and highlight existing disparities in prostate cancer.

Registration

Release Date: April 8, 2022
Expiration Date: April 7, 2023
Estimated Time to Complete: 2.0 hours
Registration Fee: FREE
*Originally recorded on March 27, 2022 

Credits

AMA PRA Category 1 Credits™ (2.00 hours), Non-Physician Participation Credit (2.00 hours), ANCC Contact Hours (2.00 hours), ACPE Contact Hours (2.00 hours)

Target Audience

Specialties – Family Medicine & Community Health, Hospital Medicine, Focused Practice, Internal Medicine, Medical Oncology

Professions – Advance Practice Nurse (APN), Nurse, Pharmacist (Pharm D)(BSPharm), Physician, Professional Nurse (RN)

Objectives

At the conclusion of this activity, learners should be able to:

  • Identify the different prostate cancer disease states in the castration-sensitive prostate cancer (CSPC) setting.
  • Navigate the lack of consensus in how to care for patients with prostate cancer in early stages of disease.
  • Explain the historical landscape of testing and screening in prostate cancer.
  • Describe the implications of health disparities in prostate cancer screening and treatment.

Accreditation

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation
American Medical Association (AMA) 

Stanford Medicine designates this Enduring Material for a maximum of 2.00 AMA PRA Category 1 CreditsTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accreditation Council of Pharmacy Education (ACPE) 
Stanford Medicine designates this knowledge-based activity for a maximum of 2 hours. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion. UAN: JA0000751-0000-22-005-H01-P

American Nurses Credentialing Center (ANCC) 
Stanford Medicine designates this internet enduring activity for a maximum of 2.0 ANCC contact hours.

For Pharmacists to Claim ACPE Credit
If you wish to apply for ACPE credit, please enter your NABP ePID# and Date of Birth in your CE Profile.
Go to Stanford’s CME portal > My CE > Profile tile > Credentials > Select NABP ePID# from the drop down and enter your ID number.
Please also enter your Date of Birth (month and day) in your profile under Basic Information.  The field will appear when you select your Profession as Pharmacist.